Editorial: Tropism, mapping, modeling, or therapy using canine adenovirus type 2 (CAV-2) vectors in the CNS
Editorial: Tropism, mapping, modeling, or therapy using canine adenovirus type 2 (CAV-2) vectors in the CNS
CAV-2, DREADDs, Parkinson's disease, coxsackievirus adenovirus receptor, gene transfer, neural circuit tracing, optogenetics, retrograde transport
Gonzalez-Dopeso Reyes, Iria
5b9b41b1-63bc-43ee-aa12-f9632ef6fd6e
Wolff, Mathieu
959a2c6f-c8fa-4544-85b9-e6b28ae2e3d8
Andrews, Melissa
ae987a2f-878e-4ae3-a7a3-a7170712096c
Kremer, Eric
b7c9030b-b2d4-4bb8-bb9d-d2ae3acce679
11 February 2021
Gonzalez-Dopeso Reyes, Iria
5b9b41b1-63bc-43ee-aa12-f9632ef6fd6e
Wolff, Mathieu
959a2c6f-c8fa-4544-85b9-e6b28ae2e3d8
Andrews, Melissa
ae987a2f-878e-4ae3-a7a3-a7170712096c
Kremer, Eric
b7c9030b-b2d4-4bb8-bb9d-d2ae3acce679
Gonzalez-Dopeso Reyes, Iria, Wolff, Mathieu, Andrews, Melissa and Kremer, Eric
(2021)
Editorial: Tropism, mapping, modeling, or therapy using canine adenovirus type 2 (CAV-2) vectors in the CNS.
Frontiers in Molecular Neuroscience, 14, [636476].
(doi:10.3389/fnmol.2021.636476).
Other
636476_Manuscript
- Accepted Manuscript
More information
Accepted/In Press date: 5 January 2021
e-pub ahead of print date: 11 February 2021
Published date: 11 February 2021
Additional Information:
Funding Information:
We thank all the authors that contributed to this Research Topic. Funding. Work in Andrews lab is funded by the Biotechnology and Biological Sciences Research Council and the International Foundation for Research in Paraplegia. Work in the Kremer lab was support by the LabEx EpiGenMed, an Investissements d'avenir program, Universit? de Montpellier, the Agence Nationale de la Recherche (ANR), ERA-Net (E-Rare) Joint Transnational Call, the Fondation pour la Recherche M?dicale/Fondation Alzheimer's, and l'Institut de G?n?tique Mol?culaire de Montpellier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Funding Information:
Work in Andrews lab is funded by the Biotechnology and Biological Sciences Research Council and the International Foundation for Research in Paraplegia. Work in the Kremer lab was support by the LabEx EpiGenMed, an Investissements d’avenir program, Université de Montpellier, the Agence Nationale de la Recherche (ANR), ERA-Net (E-Rare) Joint Transnational Call, the Fondation pour la Recherche Médicale/Fondation Alzheimer’s, and l’Institut de Génétique Moléculaire de Montpellier. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Keywords:
CAV-2, DREADDs, Parkinson's disease, coxsackievirus adenovirus receptor, gene transfer, neural circuit tracing, optogenetics, retrograde transport
Identifiers
Local EPrints ID: 446575
URI: http://eprints.soton.ac.uk/id/eprint/446575
ISSN: 1662-5099
PURE UUID: 46d5eda6-5193-434a-bdad-3043831a0bcc
Catalogue record
Date deposited: 15 Feb 2021 17:31
Last modified: 17 Mar 2024 03:44
Export record
Altmetrics
Contributors
Author:
Iria Gonzalez-Dopeso Reyes
Author:
Mathieu Wolff
Author:
Eric Kremer
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics